This demonstrates that ZFP36L1 expression is sufficient to block ASCL1 neuroendocrine differentiation and cellular proliferation in SCLC and that these phenotypes require ZFP36L1’s mRNA-binding activity. Here, ZFP36L1 is linked to small cell lung carcinoma.